SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Feb 23, 2016

DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: Feb. 23, 2016 · CIK: 0001533998 · Accession: 0001144204-16-083888

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-209002

Date

February 23, 2016

Author

Zvi Ben David

Form

CORRESP

Company

DarioHealth Corp. (DRIO) (CIK 0001533998)

Letter

LabStyle Innovations Corp.

9 Halamish Street

Caesarea Industrial Park

3088900, Israel

February 23, 2016

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: LabStyle Innovations Corp. (CIK: 0001533998)

Registration Statement No. 333-209002 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

LabStyle Innovations Corp. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on February 25, 2016 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant acknowledges that:

· should the Securities and Exchange Commission (the “Commission”) or its staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

· the action of the Commission or its staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

· The Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.

Very truly yours,
LABSTYLE INNOVATIONS CORP.

Show Raw Text

CORRESP
1
filename1.htm

LabStyle Innovations Corp.

9 Halamish Street

Caesarea Industrial Park

3088900, Israel

February 23, 2016

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    LabStyle Innovations Corp. (CIK: 0001533998)

    Registration Statement No. 333-209002 on Form S-1 (the “Registration Statement”)

Ladies and Gentlemen:

LabStyle Innovations
Corp. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration
Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that
it may become effective on February 25, 2016 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant acknowledges
that:

    ·
    should the Securities and Exchange Commission (the “Commission”) or its staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

    ·
    the action of the Commission or its staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

    ·
    The Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The Registrant
understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the
proposed public offering of the securities specified in the Registration Statement.

    Very truly yours,

    LABSTYLE INNOVATIONS CORP.

    By: /s/
    Zvi Ben David

    Zvi Ben David, Chief Financial Officer

SecProbe.io